Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122422) titled 'Digital Continuity-of-Care Platform-Based Real-World Prospective Registry Cohort Study in Newly Diagnosed Type 2 Diabetes' on April 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Ningbo First Hospital
Condition:
Newly diagnosed type 2 diabetes
Intervention:
Intensive Management Cohort:None
Digital self-service cohort:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-15
Target Sample Size: Intensive Management Cohort:300;Digital self-service cohort:400;Long-range escort cohort:300;
Countries of Recruitment:
China
To know more, vi...